Evidence map›Paper›PMID 31026734›Full record

ArticleThe International journal on drug policy2019

Stigma and drug use settings as correlates of self-reported, non-fatal overdose among people who use drugs in Baltimore, Maryland.

Carl A Latkin, Rachel E Gicquelais, Catie Clyde, Lauren Dayton, Melissa Davey-Rothwell, Danielle German, Seun Falade-Nwulia, Haneefa Saleem, Michael Fingerhood, Karin Tobin

Open access · greenAbstract read
In one paragraph

Article in The International journal on drug policy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Interventions to reduce self-stigma in people who use drugs: A systematic review.Journal of substance use and addiction treatment · 2024
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Somebody to Lean on: Understanding Self-Stigma and Willingness to Disclose in the Context of Addiction.International journal of environmental research and public health · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Carl A LatkinJohns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, United States. Electronic address: carl.latkin@jhu.edu.
Rachel E GicquelaisJohns Hopkins Bloomberg School of Public Health, Department of Epidemiology, United States.
Catie ClydeJohns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, United States.
Lauren DaytonJohns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, United States.
Melissa Davey-RothwellJohns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, United States.
Danielle GermanJohns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, United States.
Seun Falade-NwuliaJohns Hopkins School of Medicine, Division of Infectious Diseases, United States.
Haneefa SaleemJohns Hopkins Bloomberg School of Public Health, Department of International Health, United States.
Michael FingerhoodJohns Hopkins Bayview Medical Center, Department of Medicine, Chemical Dependence, United States.
Karin TobinJohns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, United States.
Johns Hopkins University · US

Funding

Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
A comprehensive approach to secondary HIV prevention and care among positivesR01DA032217 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LATKIN, CARL A · 2011 to 2015
$5.1M
The Effects of Drug Use, Depression, and Social Factors on HIV/HCV Care Continuum among PWID in Urban Areas: A Social-Network PerspectiveR01DA040488 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LATKIN, CARL A, TOBIN, KARIN E · 2015 to 2020
$4.0M
The Impact of Neighborhoods, Networks and Depression on Drug Users' HIV RisksR01DA022961 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LATKIN, CARL A · 2007 to 2011
$3.0M
An evaluation of a social network intervention for primary and secondary prevention of opioid overdoses.R01CE003021 · CE · JOHNS HOPKINS UNIVERSITY · PI LATKIN, CARL A · 2018 to 2020
$2.2M
Understanding the role of social networks in methadone maintenance treatment retention and antiretroviral therapy adherence among people who inject drugs in TanzaniaK01DA047142 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SALEEM, HANEEFA TASLEEM · 2019 to 2023
$968k
The impact of social networks on hepatitis C transmission and care access in people who inject drugsK23DA041294 · NIDA · JOHNS HOPKINS UNIVERSITY · PI FALADE-NWULIA, OLUWASEUN · 2016 to 2020
$924k
Social networks, social resources, and HIV transmissionK01DA041259 · NIDA · JOHNS HOPKINS UNIVERSITY · PI GERMAN, DANIELLE · 2016 to 2020
$829k
NCIPC CDC HHS R01 CE003021NIAID NIH HHS T32 AI102623NIDA NIH HHS K01 DA041259NIDA NIH HHS K01 DA047142NIDA NIH HHS K23 DA041294NIDA NIH HHS R01 DA022961NIDA NIH HHS R01 DA032217NIDA NIH HHS R01 DA040488
6 · The paper itself

Abstract

backgroundFatalities from opioid overdose quadrupled during the last 15 years as illicit opioid use increased. This study assesses how stigma and drug use settings are associated with non-fatal overdose to identify targets for overdose risk reduction interventions and inform overdose education and naloxone distribution programs.

methodsWe surveyed 444 people who used drugs in Baltimore, Maryland, USA, from 2009 to 2013 as part of a randomized clinical trial of a harm reduction intervention. Participants reported demographic characteristics, drug use, overdose history, use of a local syringe services program, involvement in the local drug economy, and whether they experienced discrimination from others (i.e., enacted stigma) or stigmatized themselves (i.e., internalized stigma) related to their drug use. We used multinomial logistic regression models to identify correlates of experiencing a non-fatal overdose within the past year or >1 year ago relative to participants who never experienced an overdose.

resultsStigma was positively associated with experiencing a non-fatal overdose in the past year (adjusted Odds Ratio [aOR]: 1.7, 95% Confidence Interval [CI]: 1.1-2.7) and >1 year ago (aOR [95% CI]: 1.5 [1.1-2.0]) after adjustment for demographic and substance use characteristics. The association of stigma with overdose was stronger for enacted versus internalized stigma. The number of public settings (shooting gallery, crack house, abandoned building, public bathroom, outside) where participants used drugs was also positively associated with experiencing an overdose.

conclusionsStigma related to drug use and using drugs in more settings may increase overdose risk. The effectiveness of overdose prevention and naloxone training may be improved by reducing discrimination against people who use drugs in community and medical settings and diversifying the settings in which overdose prevention trainings are delivered. These efforts may be enhanced by use of peer outreach approaches in which people who use drugs diffuse prevention messages through their social networks and within settings of drug consumption outside the medical setting.

Indexed as

Social StigmaAdolescentAdultAnalgesics, OpioidBaltimoreCase-Control StudiesDrug OverdoseDrug UsersEnvironmentFemaleHumansMaleMiddle AgedSelf ReportYoung AdultAnalgesics, OpioidDrug use settingsOverdoseStigma

Identifiers

PMID31026734
PMCPMC6535351
OpenAlexW2942137883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.